Oncternal Therapeutics, Inc. (ONCT) Financials

ONCT Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 36.7 million 6.7 million
2023-09-30 43.2 million 6.2 million
2023-06-30 50.8 million 5.6 million
2023-03-31 58.3 million 5.8 million

ONCT Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -6.4 million 2.2 million
2023-09-30 -5.5 million 1.7 million
2023-06-30 -9.3 million 1.7 million
2023-03-31 -11.0 million 1.9 million

ONCT Net Income

No data available :(

ONCT Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 34.3 million - 318000
2023-09-30 40.3 million - 342000
2023-06-30 45.5 million - 366000
2023-03-31 54.3 million - 50000

ONCT Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 2.9 million
2023-09-30 59.0 million
2023-06-30 58.7 million
2023-03-31 58.5 million

ONCT Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 6.7 million 3.3 million -
2023-09-30 - 7.5 million 3.1 million -
2023-06-30 - 6.6 million 3.1 million -
2023-03-31 - 9.0 million 3.3 million -

ONCT Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 297000 -
2023-09-30 179000 75000
2023-06-30 106000 37000
2023-03-31 203000 37000

ONCT

Price: $8.74

52 week price:
5.20
13.20

Earnings Per Share: -13.43 USD

P/E Ratio: -0.70

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 91400

Market Capitalization: 25.6 million

Links: